MRP has been identified as another multidrug-resistance (MDR) gene and may be involved in an alternative MDR mechanism in some solid tumors. We investigated the expres- sion of M R P mRNA in multidrug-resistant KB sublines (KB-8-5, KB-CZ, C -W and C A I to), human non-small-cell lung carcinomas (NSC
Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas
β Scribed by Fillpits, M; Suchomel, RW; Dekan, G; Stiglbauer, W; Haider, K; Depisch, D; Pirker, R
- Book ID
- 109837416
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 913 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The intrinsic or acquired resistance of urothelial cancer to chemotherapy is one major obstacle to successful treatment. Generally, the expression level of P-glycoprotein in urothelial cancer is low, so we accordingly investigated the expression of multidrug resistance-associated protein (MRP). We e
Treatment of hepatocellular carcinoma (HCC) by chemotherapy is often impeded by the intrinsic multidrug resistance (MDR) of this frequent primary cancer of the liver. The MDR phenotype can be caused by ATP-dependent export of chemotherapeutic drugs across the plasma membrane being mediated by transp
## BACKGROUND. We examined the relationship between the expression of a multidrug resistance-associated protein (MRP) and the biologic factors regarding invasion and metastasis of human gastric cancer. ## METHODS. In 75 patients with gastric cancer, the expression of MRP was immunohistochemical